More Underwood Capital Limited news
Underwood Capital LimitedASX: UWC

PhytoTech Therapeutics Phase 2 Clinical Trial Update

Jan 30, 2018 at 9:42 PM EST · Issued by Underwood Capital Limited

Filed with ASX · Jan 30, 2018 at 9:42 PM EST

On 6ix: 6ix.com/news/phytotech-therapeutics-phase-2-clinical-trial-update

Underwood Capital Limited has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Underwood Capital Limited on 6ix

Story so far

  • MMJ Clinical Trial Results Published in Medical JournalNov 16, 2017
  • MMJ to Commence Phase 2 Clinical Trial on Pediatric EpilepsyAug 15, 2016
  • Successful Results of Phase 1 Clinical TrialFeb 11, 2016

Earlier from Underwood Capital

  • MMJ to Acquire Strategic Position in Dosecann IncJan 29, 2018
  • Harvest One Announces C$35 Million FinancingJan 9, 2018
  • Federal Government Approves Medicinal Cannabis ExportsJan 4, 2018
  • MMJ Finalises C$2 Million Weed Me Inc. InvestmentDec 28, 2017
  • Strategic Investment in Weed Me Inc.Dec 11, 2017

Later from Underwood Capital

  • Quarterly Update and Appendix 4CJan 31, 2018
  • Harvest One Corporate UpdateJan 31, 2018
  • Harvest One Operational UpdateFeb 6, 2018
  • New CEOFeb 18, 2018
  • HVT Launches Retail Platform & Completes Initial SalesFeb 28, 2018
All Underwood Capital news releases↗

Follow Underwood Capital into a list and get an email when it puts out news.

Follow Underwood Capital
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer